Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Commentaries

Insulin Dosing for Fat and Protein: Is it Time?

  1. Carmel E.M. Smart1,2⇑,
  2. Bruce R. King1,2 and
  3. Prudence E. Lopez1,2
  1. 1John Hunter Children’s Hospital, Newcastle, New South Wales, Australia
  2. 2University of Newcastle, Newcastle, New South Wales, Australia
  1. Corresponding author: Carmel E.M. Smart, carmel.smart{at}health.nsw.gov.au
Diabetes Care 2020 Jan; 43(1): 13-15. https://doi.org/10.2337/dci19-0039
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

The impact of dietary fat and protein on postprandial glycemia in type 1 diabetes (T1D) and the need to adjust for them in the mealtime insulin dose have been controversial (1,2). Recently, carefully designed randomized trials in individuals living with T1D have shown protein and fat consumed in meals with carbohydrate reduce the early postprandial rise (1–2 h) and contribute to postprandial hyperglycemia in the late (3–6 h) postprandial period (3–5). In clinical practice, continuous glucose monitoring highlights the glycemic effects of different meal types demonstrating that mealtime insulin dosing strategies based on carbohydrate counting alone have limitations. There is a need for an evidence-based, safe, and practical method to guide insulin adjustments for high-fat, high-protein meals. In this issue of Diabetes Care, Bell et al. (6) address the pressing clinical question of optimal insulin adjustments for meals containing differing amounts of dietary fat. This is important because postprandial hyperglycemia has been identified as a risk factor for the development of long-term complications of diabetes (7), and higher fat diets have increased in popularity in recent years.

The mechanisms by which all three macronutrients impact blood glucose levels in people with T1D is shown in Fig. 1. Dietary carbohydrate is absorbed and rapidly increases the blood glucose concentration (8). Dietary protein results in a delayed and more prolonged increase in blood glucose levels by conversion of amino acids to glucose through gluconeogenesis, as well as an influence on multiple hormones including glucagon, cortisol, growth hormone, insulin-like growth factor 1, and ghrelin, thus increasing insulin resistance (9). Dietary fat also results in a delayed glycemic response by a number of mechanisms. Free fatty acids act via peroxisome proliferator–activated receptors and free fatty acid receptors to impact cellular responses to insulin, leading to increased insulin resistance (10). Fat also affects other hormones impacting glycemic regulation including glucagon, glucagon-like peptide 1, gastric inhibitory polypeptide, and ghrelin (10). Triacylglycerols in fat are metabolized to glycerol, which can be used for gluconeogenesis, although this accounts for only a small amount of triacylglycerol metabolism. Addition of fat to a meal will delay the rate of gastric emptying as the stomach empties at a constant energy rate (9).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Mechanisms by which carbohydrate, protein, and fat contribute to increasing blood glucose levels and insulin requirements in type 1 diabetes. Numbers indicate points of insulin requirement. 1, insulin is required to metabolize glucose; 2, insulin is required to stop gluconeogenesis; 3, insulin is required to stop conversion of glycogen to glucose; 4, insulin is required to counteract insulin resistance. Width of arrows indicates relative contribution to increase in blood glucose. pPARs, peroxisome proliferator–activated receptors.

Alternative algorithms such as the model predictive algorithm presented in this issue (6) are more complex than those for carbohydrate alone. Additional factors need to be considered in calculating insulin for fat and protein. In mixed meals, an adjustment based on the insulin-to-carbohydrate ratio (ICR) is needed because of the interactions between carbohydrate, fat, and protein on insulin resistance. When protein or fat are eaten alone or as part of a mixed meal, independent factors, proportional to the quantity of fat and protein, are needed to account for mechanisms such as gluconeogenesis (Fig. 1).

In order to provide clinical guidance for insulin adjustments, it is necessary to first consider the following: What is the impact of varying amounts of fat and protein on postprandial glycemia?

Previous studies in individuals with T1D have demonstrated the impact of a defined amount of fat in a meal (3,11,12). Bell et al. (6) add to these findings by demonstrating a dose response of fat in a carbohydrate-containing meal, showing dose-dependent reductions in the early postprandial period followed by increases in the late postprandial period. Data from preliminary results presented at the European Society for Paediatric Endocrinology also found that fat, when consumed alone, increases glucose levels in a dose-dependent manner (13).

The glycemic effect of protein alone (independent of carbohydrate and fat) and when consumed in a mixed meal has also been examined. When protein is consumed in isolation of carbohydrate, 75–100 g of protein needs to be consumed (equivalent to a 300-g lean steak with salad) before it has a significant impact on postprandial glycemia (5). This large protein meal produced a late (3–5 h) glycemic response similar to that of 20 g of glucose consumed without insulin (5). In comparison, when protein was consumed with 30 g of carbohydrate (no fat), amounts as low as 12.5 g contributed to a significant glycemic response in both the early and late postprandial periods (14). Paterson et al. (14) demonstrated a dose response from protein similar to that from fat reported in this issue, with dose-dependent decreases in the early postprandial period that inverted later in the postprandial period.

The question then remains, how much additional insulin is needed for fat and protein and how should it be delivered?

A number of studies have previously investigated the additional insulin required for fat and protein (4,12,15,16,17), with all reporting marked interindividual differences. In their initial study using the same model predictive algorithm, Bell et al. (6) found that for a pizza meal a dose increase of 65% was needed to prevent hyperglycemia, with the majority of participants requiring an extra 75–124% of their usual dose (4). Wolpert et al. (12) found that a high-fat meal required on average 42% more insulin than a low-fat meal, with some participants requiring more than twice as much insulin while others required no extra insulin (−17% to 108%). Gingras et al. (15) found that a high-fat, high-protein meal required on average 32% more insulin than a low-fat, low-protein meal, with some participants needing twice as much insulin while others required almost none (5–120%) (15). Recent data in children and adolescents using pump therapy found a mean additional 30% of the dose for a very high-protein meal (16) and up to 60% more for a high-fat, high-protein meal (17) may be required.

In the present study, Bell et al. (6) undertook a randomized, within-subject trial to examine the insulin requirements for incremental doses of fat. Their main finding is that the mean additional insulin required for a meal increased from 6% for both an extra 20 g and 40 g of fat to 21% for an extra 60 g of fat. Interindividual variation was high, in support of earlier studies, with half of the participants who consumed the meal with 40 g added fat requiring only their usual dose. The model predictive control algorithm holds promise as it improves postprandial area under the glucose curve following high-fat meals, without an increase in hypoglycemia (4). However, the interindividual differences highlight the challenges in clinical translation and recommendations. Habitual diet and the amounts of fat and protein typically covered by an individualized ICR may have an important influence on individual sensitivity to different macronutrients. In the present study, almost half of participants (47%) experienced hypoglycemia following the meal that contained no fat, suggesting the ICR may have been optimized for meals containing moderate fat amounts.

Very few studies have addressed the duration and split of the combination bolus. New data reported in this issue (6) show the optimal duration of the combination bolus increases with fat amount, from 73 min for 20 g of fat (75%/25%) to 105 min for 60 g of fat (50%/50%). The findings provide support for recommendations (18,19) that a greater proportion of the total insulin dose needs to be given up front (≥50%) over a shorter duration (<2 h) than previously thought. Different strategies will be required for different foods (20), and dosing algorithms will need to incorporate multiple strategies for meals of varying macronutrient compositions (21).

In conclusion, optimal postprandial glycemia depends on matching insulin to the entire meal composition. The findings presented here have implications for clinical practice: insulin is required for dietary fat, with the dose adjustment dependent on the quantity of fat and individual sensitivity. A starting point for adjusting insulin based on differing amounts of fat is recommended, which requires tailoring to the individual. It will be important for future meal algorithms to adapt over a period of time to improve performance with respect to each individual’s glycemic response. Ongoing research is needed to elucidate the implementation of routine fat and protein dosing into clinical practice.

Article Information

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Footnotes

  • See accompanying article, p. 59.

  • © 2019 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Peters AL,
    2. Davidson MB
    . Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr 1993;58:555–560
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Franz MJ
    . Protein controversies in diabetes. Diabetes Spectr 2000;13:132
    OpenUrl
  3. ↵
    1. Smart CE,
    2. Evans M,
    3. O’Connell SM, et al
    . Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care 2013;36:3897–3902
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Bell KJ,
    2. Toschi E,
    3. Steil GM,
    4. Wolpert HA
    . Optimized mealtime insulin dosing for fat and protein in type 1 diabetes: application of a model-based approach to derive insulin doses for open-loop diabetes management. Diabetes Care 2016;39:1631–1634
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Paterson MA,
    2. Smart CE,
    3. Lopez PE, et al
    . Influence of dietary protein on postprandial blood glucose levels in individuals with type 1 diabetes mellitus using intensive insulin therapy. Diabet Med 2016;33:592–598
    OpenUrlPubMed
  6. ↵
    1. Bell KJ,
    2. Fio CZ,
    3. Twigg S, et al
    . Amount and type of dietary fat, postprandial glycemia, and insulin requirements in type 1 diabetes: a randomized within-subject trial. Diabetes Care 2020;43:59–66
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Ceriello A,
    2. Hanefeld M,
    3. Leiter L, et al
    . Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004;164:2090–2095
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Newey H
    . Absorption of carbohydrates. Br Med Bull 1967;23:236–240
    OpenUrlPubMed
  9. ↵
    1. Paterson M,
    2. Bell KJ,
    3. O’Connell SM,
    4. Smart CE,
    5. Shafat A,
    6. King B
    . The role of dietary protein and fat in glycaemic control in type 1 diabetes: implications for intensive diabetes management. Curr Diab Rep 2015;15:61
    OpenUrl
  10. ↵
    1. Ježek P,
    2. Jabůrek M,
    3. Holendová B,
    4. Plecitá-Hlavatá L
    . Fatty acid-stimulated insulin secretion vs. lipotoxicity. Molecules 2018;23:1483
    OpenUrl
  11. ↵
    1. Lodefalk M,
    2. Åman J,
    3. Bang P
    . Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with type 1 diabetes. Diabet Med 2008;25:1030–1035
    OpenUrlCrossRefPubMed
  12. ↵
    1. Wolpert HA,
    2. Atakov-Castillo A,
    3. Smith SA,
    4. Steil GM
    . Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013;36:810–816
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. O'Connell SM,
    2. O'Toole N,
    3. Cronin C, et al
    . Is the glycaemic response from fat in meals dose dependent in children and adolescents with T1DM on intensive insulin therapy? (Abstract). Horm Res Paediatr 2018;90(Suppl. 1):34–35
    OpenUrl
  14. ↵
    1. Paterson MA,
    2. Smart CEM,
    3. Lopez PE, et al
    . Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with type 1 diabetes mellitus. Diabet Med 2017;34:851–854
    OpenUrlPubMed
  15. ↵
    1. Gingras V,
    2. Bonato L,
    3. Messier V, et al
    . Impact of macronutrient content of meals on postprandial glucose control in the context of closed-loop insulin delivery: a randomized cross-over study. Diabetes Obes Metab 2018;20:2695–2699
    OpenUrl
  16. ↵
    1. Paterson MA,
    2. Smart CE,
    3. Rafferty J, et al
    . A 30% increased insulin dose is necessary to control postprandial hyperglycemia for high protein meals in individuals with type 1 diabetes using insulin pump therapy (Abstract). Diabetes 2019;68(Suppl. 1):330-OR
    OpenUrlCrossRef
  17. ↵
    1. Smith T,
    2. Fuery M,
    3. Knight B, et al
    . In young people using insulin pump therapy an additional sixty percent of the mealtime insulin dose improves postprandial glycaemia following a high fat, high protein meal (Abstract). Pediatr Diabetes 2018;19(Suppl. 26):131–132
    OpenUrl
  18. ↵
    1. Lopez P,
    2. Smart C,
    3. Morbey C,
    4. McElduff P,
    5. Paterson M,
    6. King BR
    . Extended insulin boluses cannot control postprandial glycemia as well as a standard bolus in children and adults using insulin pump therapy. BMJ Open Diabetes Res Care 2014;2:e000050
    OpenUrl
  19. ↵
    1. Evans M,
    2. Smart CEM,
    3. Paramalingam N, et al
    . Dietary protein affects both the dose and pattern of insulin delivery required to achieve postprandial euglycaemia in type 1 diabetes: a randomized trial. Diabet Med 2019;36:499–504
    OpenUrl
  20. ↵
    1. Zanfardino A,
    2. Confetto S,
    3. Curto S, et al
    . Demystifying the pizza bolus: the effect of dough fermentation on glycemic response—a sensor-augmented pump intervention trial in children with type 1 diabetes mellitus. Diabetes Technol Ther. 8 August 2019 [Epub ahead of print]. DOI: 10.1089/dia.2019.0191
  21. ↵
    1. Goodwin GC,
    2. Seron MM
    . A performance bound for optimal insulin infusion in individuals with type 1 diabetes ingesting a meal with slow postprandial response. Automatica 2019;103:531–537
    OpenUrl
PreviousNext
Back to top
Diabetes Care: 43 (1)

In this Issue

January 2020, 43(1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Insulin Dosing for Fat and Protein: Is it Time?
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Insulin Dosing for Fat and Protein: Is it Time?
Carmel E.M. Smart, Bruce R. King, Prudence E. Lopez
Diabetes Care Jan 2020, 43 (1) 13-15; DOI: 10.2337/dci19-0039

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Insulin Dosing for Fat and Protein: Is it Time?
Carmel E.M. Smart, Bruce R. King, Prudence E. Lopez
Diabetes Care Jan 2020, 43 (1) 13-15; DOI: 10.2337/dci19-0039
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Apps and the Woman With Gestational Diabetes Mellitus
  • The Prognostic Value of Time in Range in Type 2 Diabetes
  • Spontaneous or Deliberate: Effects of Acute Variations in Glycemia on Gastric Emptying in Type 1 Diabetes
Show more Commentaries

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.